Cloning-free genome engineering in Sinorhizobium meliloti advances applications of Cre/loxP site-specific recombination.

J Biotechnol

LOEWE Center for Synthetic Microbiology and Faculty of Biology, Philipps-Universität Marburg, Marburg, Germany. Electronic address:

Published: September 2016

The soil-dwelling α-proteobacterium Sinorhizobium meliloti serves as model for studies of symbiotic nitrogen fixation, a highly important process in sustainable agriculture. Here, we report advancements of the genetic toolbox accelerating genome editing in S. meliloti. The hsdMSR operon encodes a type-I restriction-modification (R-M) system. Transformation of S. meliloti is counteracted by the restriction endonuclease HsdR degrading DNA which lacks the appropriate methylation pattern. We provide a stable S. meliloti hsdR deletion mutant showing enhanced transformation with Escherichia coli-derived plasmid DNA and demonstrate that using an E. coli plasmid donor, expressing S. meliloti methyl transferase genes, is an alternative strategy of increasing the transformation efficiency of S. meliloti. Furthermore, we devise a novel cloning-free genome editing (CFGE) method for S. meliloti, Agrobacterium tumefaciens and Xanthomonas campestris, and demonstrate the applicability of this method for intricate applications of the Cre/lox recombination system in S. meliloti. An enhanced Cre/lox system, allowing for serial deletions of large genomic regions, was established. An assay of lox spacer mutants identified a set of lox sites mediating specific recombination. The availability of several non-promiscuous Cre recognition sites enables simultaneous specific Cre/lox recombination events. CFGE combined with Cre/lox recombination is put forward as powerful approach for targeted genome editing, involving serial steps of manipulation to expedite the genetic accessibility of S. meliloti as chassis.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jbiotec.2016.06.033DOI Listing

Publication Analysis

Top Keywords

genome editing
12
cre/lox recombination
12
meliloti
10
cloning-free genome
8
sinorhizobium meliloti
8
recombination
5
genome engineering
4
engineering sinorhizobium
4
meliloti advances
4
advances applications
4

Similar Publications

Taming the wild: domesticating untapped northern fruit tree and shrub resources in the era of high-throughput technologies.

AoB Plants

January 2025

Department of Plant Science, McGill University, Macdonald Campus, 21111 Rue Lakeshore, Ste-Anne-de-Bellevue, H9X 3V9, Québec, Canada.

New crop`s need to emerge to provide sustainable solutions to climate change and increasing abiotic and biotic constraints on agriculture. A large breadth of northern fruit trees and shrubs exhibit a high potential for domestication; however, obstacles to implementing traditional breeding methods have hampered or dissuaded efforts for improvement. This review article proposes a unique roadmap for domestication of northern fruit crops, with a focus on biotechnological (e.

View Article and Find Full Text PDF

Cas12a is a next-generation gene editing tool that enables multiplexed gene targeting. Here, we present a mouse model that constitutively expresses enhanced Acidaminococcus sp. Cas12a (enAsCas12a) linked to an mCherry fluorescent reporter.

View Article and Find Full Text PDF

sgRNA Single-Nucleotide Resolution by Ion-Pairing Reversed-Phase Chromatography.

Anal Chem

January 2025

Synthetic Molecule Design and Development, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana 46285, United States.

Single-stranded guide RNAs (sgRNAs) are important therapeutic modalities that facilitate selective genome editing by the CRISPR/Cas9 system. While these therapeutic modalities are synthesized through solid phase oligonucleotide synthesis similar to small interfering RNA (siRNAs) and antisense oligonucleotide (ASOs) therapeutics, their sequence length and complex secondary and tertiary structure hinder analytical characterization. The resulting current sgRNA methodologies have limited chromatographic selectivity near the FLP and limited MS compatibility.

View Article and Find Full Text PDF

Exosome-mediated CRISPR/Cas delivery: A cutting-edge frontier in cancer gene therapy.

Gene

January 2025

Cancer and Stem Cell Biology Laboratory, Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, TamilNadu 603203, India. Electronic address:

Cancer is considered the second most common disease globally. In the past few decades, many approaches have been proposed for cancer treatment. One among those is targeted therapy using CRISPR-Cas system which plays an irreplaceable role in translational research through gene editing.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!